Skip to content

Zymeworks ZYME PP&E (Net)

PP&E (Net) at other companies

Pfizer logo
PfizerPFE
$19.4B+5.8%
Amgen logo
AmgenAMGN
$8.22B+23.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.28M-26.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.13M-2.8%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.4M-6.0%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$21.7M+17.6%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's PP&E (net)?
Zymeworks (ZYME) reported PP&E (net) of $14.85M in Q1 2026.
How has Zymeworks's PP&E (net) changed year-over-year?
Zymeworks's PP&E (net) decreased by 11.0% year-over-year, from $16.69M to $14.85M.
What is the long-term trend for Zymeworks's PP&E (net)?
Over 4 years (2021 to 2025), Zymeworks's PP&E (net) has grown at a -9.2% compound annual growth rate (CAGR), from $22.78M to $15.5M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.